Weijie Li Selected Research

guizhi decoction

1/2022	A Novel Drug Combination of Mangiferin and Cinnamic Acid Alleviates Rheumatoid Arthritis by Inhibiting TLR4/NFκB/NLRP3 Activation-Induced Pyroptosis.
1/2021	Disease-Modifying Anti-rheumatic Drug Prescription Baihu-Guizhi Decoction Attenuates Rheumatoid Arthritis via Suppressing Toll-Like Receptor 4-mediated NLRP3 Inflammasome Activation.
2/2020	Deciphering the chemical profile and pharmacological mechanisms of Baihu-Guizhi decoction using ultra-fast liquid chromatography-quadrupole-time-of-flight tandem mass spectrometry coupled with network pharmacology-based investigation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weijie Li Research Topics

Disease

15	Neoplasms (Cancer) 03/2022 - 01/2012
12	Rheumatoid Arthritis 09/2022 - 03/2002
11	Inflammation (Inflammations) 12/2022 - 01/2012
6	Insulin Resistance 06/2013 - 02/2005
5	Lung Neoplasms (Lung Cancer) 03/2022 - 11/2013
4	Infections 01/2021 - 01/2014
4	Atherosclerosis 12/2012 - 02/2010
4	Type 2 Diabetes Mellitus (MODY) 12/2011 - 06/2004
3	Crohn Disease (Crohn's Disease) 01/2021 - 01/2020
3	Hyperplasia 08/2019 - 01/2007
3	Hypoxia (Hypoxemia) 10/2017 - 01/2011
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2016 - 03/2015
2	Myocardial Infarction 01/2022 - 07/2014
2	Carcinogenesis 01/2022 - 01/2021
2	Asthma (Bronchial Asthma) 01/2022 - 02/2002
2	Arthritis (Polyarthritis) 01/2022 - 01/2021
2	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2017
2	Infarction (Infarctions) 07/2021 - 02/2003
2	Fibrosis (Cirrhosis) 03/2020 - 07/2014
2	Hepatocellular Carcinoma (Hepatoma) 10/2019 - 09/2012
2	Hepatitis 01/2019 - 01/2014
2	Hepatitis B 02/2018 - 01/2014
2	Liver Neoplasms (Liver Cancer) 01/2018 - 09/2012
2	Adenocarcinoma of Lung 02/2016 - 11/2013
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2015 - 03/2013
2	Autoimmune Diseases (Autoimmune Disease) 03/2013 - 08/2003
2	Hyperglycemia 12/2011 - 02/2005
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2009 - 03/2008
2	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2008 - 02/2007
1	Death (Near-Death Experience) 01/2022
1	Hemorrhage 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 03/2020 - 03/2002
9	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2014
6	Pharmaceutical PreparationsIBA 01/2021 - 11/2013
5	TabletsIBA 01/2021 - 01/2018
5	Glucose (Dextrose)FDA LinkGeneric 10/2015 - 02/2005
5	Insulin (Novolin)FDA Link 01/2013 - 06/2004
4	LigandsIBA 01/2022 - 01/2014
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2012
4	GlycosidesIBA 01/2021 - 01/2018
4	Phosphotransferases (Kinase)IBA 03/2015 - 01/2007
4	AdiponectinIBA 01/2013 - 06/2004
3	Drug CombinationsIBA 09/2022 - 01/2020
3	guizhi decoctionIBA 01/2022 - 02/2020
3	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2015
3	ChemokinesIBA 01/2022 - 01/2020
3	Adenosine Triphosphate (ATP)IBA 01/2021 - 12/2011
3	Biological ProductsIBA 01/2021 - 12/2012
3	ErbB Receptors (EGF Receptor)IBA 07/2016 - 02/2007
3	Messenger RNA (mRNA)IBA 01/2015 - 02/2007
3	Pioglitazone (Actos)FDA Link 06/2013 - 06/2004
2	LipidsIBA 12/2022 - 01/2016
2	mangiferinIBA 09/2022 - 01/2022
2	InflammasomesIBA 01/2022 - 01/2021
2	ORALIT (ORS)IBA 01/2022 - 01/2022
2	Competitive Endogenous RNAIBA 01/2022 - 10/2020
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 02/2020
2	src-Family KinasesIBA 01/2021 - 12/2009
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 02/2005
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2020 - 02/2002
2	peoniflorinIBA 01/2020 - 01/2020
2	Liposomes (Liposome)IBA 12/2019 - 01/2014
2	Small Interfering RNA (siRNA)IBA 12/2019 - 01/2014
2	Folic Acid (Vitamin M)FDA LinkGeneric 12/2019 - 01/2014
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2019 - 02/2003
2	Hepatitis B e AntigensIBA 02/2018 - 01/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 01/2014
2	Tyrosine Kinase InhibitorsIBA 07/2016 - 02/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 11/2013
2	Toll-Like Receptor 4IBA 10/2015 - 01/2011
2	CoumarinsIBA 10/2015 - 03/2013
2	ThiazolidinedionesIBA 06/2013 - 06/2004
2	Plasminogen Activator Inhibitor 1IBA 12/2012 - 02/2010
2	CathepsinsIBA 08/2003 - 03/2002
2	Cathepsin KIBA 07/2002 - 03/2002
1	Glycyrrhizic Acid (Glycyrrhizin)IBA 09/2022
1	Long Noncoding RNAIBA 03/2022
1	Antineoplastic Agents (Antineoplastics)IBA 03/2022
1	Actins (F Actin)IBA 03/2022
1	ZeaxanthinsIBA 01/2022
1	CryptoxanthinsIBA 01/2022
1	Interleukin-18 (Interleukin 18)IBA 01/2022
1	cinnamic acidIBA 01/2022
1	Carotenoids (Carotene)IBA 01/2022
1	LycopeneIBA 01/2022
1	LuteinIBA 01/2022
1	ChloridesIBA 07/2021
1	Chimeric Antigen ReceptorsIBA 01/2021
1	N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA 01/2021

Therapy/Procedure

16	Therapeutics 09/2022 - 06/2004
7	Drug Therapy (Chemotherapy) 01/2022 - 11/2013
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 03/2013
2	Precision Medicine 01/2021 - 01/2018
2	Stents 02/2019 - 03/2002
1	Photothermal Therapy 03/2022
1	Radiotherapy 01/2022
1	Adjuvant Chemotherapy 01/2022
1	Modified Radical Mastectomy (Mastectomy, Modified) 01/2022